Core Laboratories (NYSE:CLB) Releases Q3 2026 Earnings Guidance

Core Laboratories (NYSE:CLB) updated its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.120-0.200 for the period, compared to the consensus EPS estimate of 0.170. The company issued revenue guidance of $128.5 million-$135.5 million, compared to the consensus revenue estimate of $132.5 million.

Core Laboratories Price Performance

Core Laboratories stock traded down $0.82 on Wednesday, reaching $9.87. The company’s stock had a trading volume of 1,604,259 shares, compared to its average volume of 590,079. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The company has a market cap of $454.75 million, a price-to-earnings ratio of 15.18, a PEG ratio of 2.71 and a beta of 1.00. The business’s fifty day moving average price is $12.24 and its 200 day moving average price is $15.38. Core Laboratories has a twelve month low of $9.72 and a twelve month high of $20.36.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.03. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Equities analysts expect that Core Laboratories will post 0.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CLB has been the topic of several research analyst reports. Wall Street Zen cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Weiss Ratings cut shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, June 24th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Hedge Funds Weigh In On Core Laboratories

Institutional investors and hedge funds have recently made changes to their positions in the company. Platinum Investment Management Ltd. raised its stake in Core Laboratories by 3.9% during the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock worth $294,000 after buying an additional 889 shares during the period. The Manufacturers Life Insurance Company grew its stake in Core Laboratories by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock valued at $207,000 after acquiring an additional 1,040 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Core Laboratories by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock valued at $418,000 after acquiring an additional 1,170 shares during the period. Quarry LP increased its holdings in shares of Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after acquiring an additional 1,599 shares in the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Core Laboratories in the fourth quarter worth about $34,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.